Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Background The site of action of the 5-fluorouracil (5-FU) antitumor effect has been explicated in recent years. Many studies have investigated enzymes involved in 5-FU metabolism in attempts to predict this effect, and a correlation of enzyme activity with the 5-FU drug sensitivity test has been reported. The aim of this study was to identify the biochemical response determinants of 5-FU. Additionally, we aimed to clarify the association between cell proliferative activity and the response to 5-FU of colorectal cancer.Methods Our research subjects were 54 patients with colorectal carcinoma who had undergone operations between August 1999 and July 2001 in our department. Assays of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), and orotate phosphoribosyltransferase (OPRT) activities in colorectal carcinoma tissue and assays of 5-FU sensitivity by the collagen gel droplet embedded culture drug sensitivity test (CD-DST) were conducted to investigate the relationships between each enzyme activity and 5-FU sensitivity. In addition, the proliferative activity of cancer cells was evaluated with Ki-67 antibody, and the relationship of this activity to each enzyme activity and 5-FU sensitivity were investigated.Results 5-FU sensitivity was high in the low-TS-activity group and in the high-OPRT-activity group. Cancers with high cell proliferative activity showed good sensitivity to 5-FU, and TS and OPRT activities were high in such cancers.Conclusion The results suggest that OPRT activity can predict sensitivity to 5-FU, and high OPRT activity may cause good 5-FU sensitivity in cancers with high cell proliferative activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been proven that the lower expression of these metabolic enzymes is associated with 5-FU resistance in CRC patients [6,7,8].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [6]
Citations
Cites
Salonga, D. S., Danenberg, K. D., Johnson, M. R., Metzger, R., Groshen, S. G., Tsao-Wei, D. D., Lenz, H.-J., Leichman, C. G., Leichman, L., Diasio, R. B., et al. (2000) · PubMed · Cited by 829
Johnston, P. G., Lenz, H.-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., & Leichman, L. (1995) · PubMed · Cited by 672
Diasio, R. B., Beavers, T. L., & Carpenter, J. T. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113308 · Cited by 503
Johnston, P. G., Fisher, E. R., Rockette, H. E., Fisher, B., Wolmark, N., Drake, J. C., Chabner, B. A., & Allegra, C. J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2640 · Cited by 405
Chemotherapy for Colorectal Cancer
Wood, A. J. J., & Moertel, C. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404213301608 · Cited by 372
Etienne, M. C., Chéradame, S., Fischel, J. L., Formento, P., Dassonville, O., Renée, N., Schneider, M., Thyss, A., Demard, F., & Milano, G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1663 · Cited by 281 · cited 1×
“Previous investigations of TS mainly measured protein levels; however, the present investigation measured TS enzyme activity by means of a tritium release method.(7) The tissue sample was homogenized in 50mmol/l TrisHCl (pH 7.”
MethodBeck, A., Etienne, M. C., Chéradame, S., Fischel, J. L., Formento, P., Renée, N., & Milano, G. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00216-r · Cited by 270
Aschele, C., Debernardis, D., Casazza, S., Antonelli, G., Tunesi, G., Baldo, C., Lionetto, R., Maley, F., & Sobrero, A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1760 · Cited by 203
Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.
Spears, C. P., Gustavsson, B. G., Berne, M., Frösing, R., Bernstein, L., & Hayes, A. A. (1988) · PubMed · Cited by 138
Cascinu, S., Aschele, C., Barni, S., Debernardis, D., Baldo, C., Tunesi, G., Catalano, V., Giordani, P., Baldelli, A. M., & Catalano, G. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)80648-0 · Cited by 122
Cited by
Blondy, S., David, V., Verdier, M., Mathonnet, M., Perraud, A., & Christou, N. (2020) · Cancer Science · doi:10.1111/cas.14532 · Cited by 507
Boyer, J., McLean, E. G., Aroori, S., Wilson, P., McCulla, A., Carey, P. D., Longley, D. B., & Johnston, P. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0362 · Cited by 229
“Recent clinical data also suggest that OPRT activity can predict sensitivity to 5-FU in CRC patients, with high levels correlating with increased sensitivity (38, 39).”
BackgroundDrug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
Ashique, S., Bhowmick, M., Pal, R., Khatoon, H., Kumar, P., Sharma, H., Garg, A., Kumar, S., & Das, U. (2024) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2024.100114 · Cited by 139
Ichikawa, W., Uetake, H., Shirota, Y., Yamada, H., Takahashi, T., Nihei, Z., Sugihara, K., Sasaki, Y., & Hirayama, R. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601335 · Cited by 129
“Recently, in studies using human colorectal cancer tissues, a higher OPRT enzyme activity was observed in 5-FU-sensitive tissues than nonsensitive ones in in vitro chemosensitivity test (Isshi et al, 2002; Fujii et al, 2003).”
BackgroundResult
Metadata
- Authors
- Fujii, R., Seshimo, A., & Kameoka, S.
- Affiliations
- Tokyo Women's Medical University (JP)
- Corresponding author
- Fujii, R.
- Venue
- International Journal of Clinical Oncology
- Published
- 2003-04-01
- Volume
- 8
- Issue
- 2
- Pages
- 72-78
- ISSN
- 1341-9625 (ISSN-L)
- 1437-7772
- OpenAlex
- W1966603374
- Cited by
- 82
- References
- 25
- Citations by year
- 2024: 5 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2015: 6 · 2014: 1 · 2013: 3 · 2012: 5
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, 5-fluorouracil sensitivity, colorectal cancer, Ki-67, drug response prediction
- MeSH terms
- Adenocarcinoma, Adult, Aged, Aged, 80 and over, Biopsy, Needle, Cell Division, Female, Fluorouracil, Humans, Immunohistochemistry, Male, Middle Aged, Neoplasm Staging, Orotate Phosphoribosyltransferase, Oxidoreductases, Probability, Prospective Studies, Sampling Studies, Sensitivity and Specificity, Thymidylate Synthase, Tumor Cells, Cultured, Biomarkers, Tumor, Colorectal Neoplasms, Statistics, Nonparametric, Drug Resistance, Neoplasm, Dihydrouracil Dehydrogenase (NADP)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.